Description
An authenticated parameter injection vulnerability exists in the web-based management interface of the AOS-8 and AOS-10 Operating Systems. Successful exploitation could allow an authenticated user to leverage parameter injection to overwrite arbitrary system files.
Published: 2025-01-14
Score: 7.2 High
EPSS: < 1% Very Low
KEV: No
Impact: n/a
Action: n/a
AI Analysis

No analysis available yet.

Remediation

No remediation available yet.

Tracking

Sign in to view the affected projects.

Advisories
Source ID Title
EUVD EUVD EUVD-2025-3094 An authenticated parameter injection vulnerability exists in the web-based management interface of the AOS-8 and AOS-10 Operating Systems. Successful exploitation could allow an authenticated user to leverage parameter injection to overwrite arbitrary system files.
History

Thu, 23 Jan 2025 22:15:00 +0000

Type Values Removed Values Added
Weaknesses CWE-94

Wed, 15 Jan 2025 16:15:00 +0000

Type Values Removed Values Added
Metrics ssvc

{'options': {'Automatable': 'no', 'Exploitation': 'none', 'Technical Impact': 'total'}, 'version': '2.0.3'}


Tue, 14 Jan 2025 17:45:00 +0000

Type Values Removed Values Added
Description An authenticated parameter injection vulnerability exists in the web-based management interface of the AOS-8 and AOS-10 Operating Systems. Successful exploitation could allow an authenticated user to leverage parameter injection to overwrite arbitrary system files.
Title Authenticated Remote Code Execution in AOS Web-based Management Interface
References
Metrics cvssV3_1

{'score': 7.2, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H'}


Subscriptions

No data.

cve-icon MITRE

Status: PUBLISHED

Assigner: hpe

Published:

Updated: 2025-01-23T21:18:23.255Z

Reserved: 2025-01-10T16:27:25.924Z

Link: CVE-2025-23051

cve-icon Vulnrichment

Updated: 2025-01-15T15:00:55.216Z

cve-icon NVD

Status : Deferred

Published: 2025-01-14T18:16:05.813

Modified: 2026-04-15T00:35:42.020

Link: CVE-2025-23051

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses